Every Form 4 that Tiziana Life Sciences Ltd Com (TLSA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TLSA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TLSA filings page.
Tiziana Life Sciences Ltd insider Gabriele M. Cerrone, a director and ten percent owner, indirectly purchased 42,357 shares of common stock on July 21, 2026 at $0.99 per share, through Panetta Partners Limited. Following this open-market purchase, indirect holdings total 44,814,587 shares. The Form 4/A corrects the earliest transaction date and transaction code for this purchase; no other reported transactions are changed.
Tiziana Life Sciences Ltd director and ten percent owner Gabriele M. Cerrone, through Panetta Partners Limited, purchased 15,000 shares of common stock in an open-market transaction at $1.11 per share on June 12, 2026, bringing indirect holdings to 44,772,230 shares. This amended report updates only the transaction code associated with that purchase.
Tiziana Life Sciences Ltd Chief Executive Officer Ivor Elrifi, through a trust, purchased a total of 321,423 shares of common stock in two open-market or private transactions. The trust bought 237,616 shares at $1.00 per share on August 5, 2026 and 83,807 shares at $0.97 per share on August 4, 2026. The holdings are reported as indirect, "By trust", and the Rule 10b5-1 trading-plan checkbox is not marked.
Tiziana Life Sciences Ltd reported that Chief Executive Officer Ivor Elrifi, through a trust, purchased 667,000 shares of common stock on 2026-08-03 at 1.0000 per share in an open-market or private transaction. Following this purchase, his indirectly held stake by trust is 4,472,261 shares.
Tiziana Life Sciences Ltd reported that director and ten percent owner Gabriele M. Cerrone, holding indirectly via Panetta Partners Limited, received a grant/award of 42,357 shares of common stock on July 21, 2026 at $0.99 per share. Following this indirect acquisition, his associated holdings total 44,814,587 common shares.
Tiziana Life Sciences Ltd reported that major shareholder and director Gabriele M. Cerrone indirectly acquired 15,000 shares of common stock as a grant or award. The shares were credited on June 12, 2026 at $1.11 per share via Panetta Partners Limited, bringing his reported indirect holdings to 44,772,230 shares of common stock.